Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 11,632 | 12,571 | 4,681 | 1,232 | 944 |
| Operating Income | -11,632 | -12,571 | -4,681 | -1,232 | -944 |
| Interest Expense | 277 | 3,938 | 395 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 1,816 | 189 |
| Pre-tax Income | -11,909 | -16,509 | -5,076 | 584 | -755 |
| Income Tax | 3 | 10 | 32 | N/A | N/A |
| Net Income Continuous | -11,912 | -16,519 | -5,108 | 584 | -755 |
| Minority Interests | N/A | -76 | -166 | N/A | N/A |
| Net Income | $-11,912 | $-16,443 | $-4,942 | $584 | $-755 |
| EPS Basic Total Ops | -8.96 | -394.94 | -663.12 | -9.45 | -8.10 |
| EPS Basic Continuous Ops | -8.96 | -396.76 | -685.44 | 23.49 | -30.86 |
| EPS Diluted Total Ops | -8.96 | -394.94 | -663.12 | -9.45 | -8.10 |
| EPS Diluted Continuous Ops | -8.96 | -396.76 | -685.44 | 23.49 | -30.86 |
| EPS Diluted Before Non-Recurring Items | -8.96 | -395.20 | N/A | N/A | N/A |
| EBITDA(a) | $-11,618 | $-12,546 | $-4,636 | $-1,232 | $-944 |